Vous êtes ici

Des chercheurs francophones à l'honneur - 2022

Décembre 2022

Charpentier E, Redheuil A, Bourron O, Boussouar S, Lucidarme O, Zarai M, Kachenoura N, Bouazizi K, Salem JE, Hekimian G, Kerneis M, Amoura Z, Allenbach Y, Hatem S, Jeannin AC, Andreelli F, Phan F; COVID-19 APHP. SU Group. Cardiac adipose tissue volume assessed by computed tomography is a specific and independent predictor of early mortality and critical illness in COVID-19 in type 2-diabetic patients. Cardiovasc Diabetol. 2022 Dec 31;21(1):294. doi: 10.1186/s12933-022-01722-2. PMID: 36587209
 
Hureau C. Can the level of copper in the hippocampus witness type-II diabetes versus Alzheimer's disease? EBioMedicine. 2022 Dec 12;87:104403. doi: 10.1016/j.ebiom.2022.104403. Epub ahead of print. PMID: 36516609; PMCID: PMC9768223
 
Jlali I, Heyman E, Matran R, Marais G, Descatoire A, Rabasa-Lhoret R, Touil I, Pawlak-Chaouch M, Mucci P, Fontaine P, Baquet G, Tagougui S. Respiratory function in uncomplicated type 1 diabetes: blunted during exercise even though normal at rest! Diabet Med. 2022 Dec 31:e15036. doi: 10.1111/dme.15036. Epub ahead of print. PMID: 36585956
 
Myette-Côté É, Molveau J, Wu Z, Raffray M, Devaux M, Tagougui S, Rabasa-Lhoret R. A Randomized Crossover Pilot Study Evaluating Glucose Control During Exercise Initiated 1 or 2 h After a Meal in Adults with Type 1 Diabetes Treated with an Automated Insulin Delivery System. Diabetes Technol Ther. 2022 Dec 6. doi: 10.1089/dia.2022.0338. Epub ahead of print. PMID: 36399114
 
Scheen AJ, Lefèbvre PJ. Glucagon, from past to present: a century of intensive research and controversies. Lancet Diabetes Endocrinol. 2022 Dec 22:S2213-8587(22)00349-7. doi: 10.1016/S2213-8587(22)00349-7. Epub ahead of print. PMID: 36566754
 
Wendeu-Foyet G, Bellicha A, Chajès V, Huybrechts I, Bard JM, Debras C, Srour B, Sellem L, Fezeu LK, Julia C, Kesse-Guyot E, Agaësse C, Druesne-Pecollo N, Galan P, Hercberg S, Deschasaux-Tanguy M, Touvier M. Different Types of Industry-Produced and Ruminant Trans Fatty Acid Intake and Risk of Type 2 Diabetes: Findings From the NutriNet-Santé Prospective Cohort. Diabetes Care. 2022 Dec 21:dc220900. doi: 10.2337/dc22-0900. Epub ahead of print. PMID: 36542554

 

Novembre 2022

Bonnefond A. Women in diabetes research: we can do better. Diabetologia. 2022 Nov 26. doi: 10.1007/s00125-022-05825-z. Epub ahead of print. PMID: 36435839
 
Creuzot-Garcher C, Massin P, Srour M, Baudin F, Dot C, Nghiem-Buffet S, Girmens JF, Collin C, Ponthieux A, Delcourt C. Epidemiology of Treated Diabetes Ocular Complications in France 2008-2018-The LANDSCAPE French Nationwide Study. Pharmaceutics. 2022 Oct 28;14(11):2330. doi: 10.3390/pharmaceutics14112330. PMID: 36365148; PMCID: PMC9697089
 
Dantan E, Pailler M, Ragot S, Gand E, Trochu JN, Cariou B, Saulnier PJ, Hadjadj S; SURDIAGENE study group. Renal function decline and heart failure hospitalisation in patients with type 2 diabetes: Dynamic predictions from the prospective SURDIAGENE cohort. Diabetes Res Clin Pract. 2022 Nov 12;194:110152. doi: 10.1016/j.diabres.2022.110152. Epub ahead of print. PMID: 36375567
 
Guerci B, Roussel R, Levrat-Guillen F, Detournay B, Vicaut E, De Pouvourville G, Emery C, Riveline JP. Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France. Diabetes Technol Ther. 2022 Nov 24. doi: 10.1089/dia.2022.0271. Epub ahead of print. PMID: 36094418
 
Myette-Cote E, Molveau J, Wu Z, Raffray M, Devaux M, Tagougui S, Rabasa-Lhoret R. A randomized crossover pilot study evaluating glucose control during exercise initiated 1 or 2h after a meal in adults with type 1 diabetes treated with an automated insulin delivery system. Diabetes Technol Ther. 2022 Nov 18. doi: 10.1089/dia.2022.0338. Epub ahead of print. PMID: 36399114
 
Naïditch N, Mauchant C, Benabbad I, Hehn C, Joubert M, Thébaut JF, Rosilio M. STYLCONNECT Study: An Assessment of Automatic Data Collection Devices by People Living with Diabetes and Using an Insulin Pen. Diabetes Ther. 2022 Nov 23. doi: 10.1007/s13300-022-01337-6. Epub ahead of print. PMID: 36422803
 
Petria I, Albuquerque S, Varoquaux G, Vie JJ, Venteclef N, Mohammedi K, Roussel R, Camoin M, Perseghin G, Velho G, Potier L. Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC population. Cardiovasc Diabetol. 2022 Nov 17;21(1):247. doi: 10.1186/s12933-022-01689-0. PMID: 36397092; PMCID: PMC9670666
 
Vergès B, Aboyans V, Angoulvant D, Boutouyrie P, Cariou B, Hyafil F, Mohammedi K, Amarenco P. Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms. Cardiovasc Diabetol. 2022 Nov 15;21(1):242. doi: 10.1186/s12933-022-01686-3. PMID: 36380358; PMCID: PMC9667639

 

Octobre 2022

Bour C, Ahne A, Aguayo G, Fischer A, Marcic D, Kayser P, Fagherazzi G. Global diabetes burden: analysis of regional differences to improve diabetes care. BMJ Open Diabetes Res Care. 2022 Oct;10(5):e003040. doi: 10.1136/bmjdrc-2022-003040. PMID: 36307139
 
Diallo A, Carlos-Bolumbu M, Galtier F. Age, sex, race, BMI, and duration of diabetes differences in cardiovascular outcomes with glucose lowering drugs in type 2 diabetes: A systematic review and meta-analysis. EClinicalMedicine. 2022 Oct 12;54:101697. doi: 10.1016/j.eclinm.2022.101697. PMID: 36263397 ; PMCID: PMC9574412
 
Diallo A, Carlos-Bolumbu M, Renard PE, Galtier F. Larger effect size in composite kidney outcomes than in major cardiovascular events associated with sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with glucagon-like peptide-1 receptor agonists (GLP-1RAs): A pooled analysis of type 2 diabetes trials. Diabetes Obes Metab. 2022 Sep 3. doi: 10.1111/dom.14859. Epub ahead of print. PMID: 36057779
 
Hadjadj S, Saulnier PJ, Ruan Y, Zhu X, Pekmezaris R, Marre M, Halimi JM, Wargny M, Rea R, Gourdy P, Cariou B, Myers AK, Khunti K; CORONADO, the ABCD COVID-19 diabetes national audit and AMERICADO investigators. Associations of microvascular complications with all-cause death in patients with diabetes and COVID-19: The CORONADO, ABCD COVID-19 UK national audit and AMERICADO study groups. Diabetes Obes Metab. 2022 Aug 20:10.1111/dom.14845. doi: 10.1111/dom.14845. Epub ahead of print. PMID: 36053971 ; PMCID: PMC9538242
 
Llauradó G, Vlacho B, Wargny M, Ruan Y, Franch-Nadal J, Domingo P, Gourdy P, Saulnier PJ, Hadjadj S, Wild SH, Rea R, Cariou B, Khunti K, Mauricio D; CORONADO, the ABCD COVID-19 diabetes national audit, HM Hospitales investigators and the Hospital del Mar - Hospital de la Santa Creu i Sant Pau Diabetes Research Group. The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19). Cardiovasc Diabetol. 2022 Oct 19;21(1):216. doi: 10.1186/s12933-022-01657-8. PMID: 36261811 ; PMCID: PMC9580453

 

Septembre 2022

Benhamou PY, Adenis A, Tourki Y, Pou S, Madrolle S, Franc S, Kariyawasam D, Beltrand J, Klonoff DC, Charpentier G. Efficacy of a Hybrid Closed-Loop Solution in Patients With Excessive Time in Hypoglycaemia: A Post Hoc Analysis of Trials With DBLG1 System. J Diabetes Sci Technol. 2022 Sep 29:19322968221128565. doi: 10.1177/19322968221128565. Epub ahead of print. PMID: 36172702
 
Bonnet JB, Sultan A. Social Deprivation, Healthcare Access and Diabetic Foot Ulcer: A Narrative Review. J Clin Med. 2022 Sep 15;11(18):5431. doi: 10.3390/jcm11185431. PMID: 36143078 ; PMCID: PMC9501414
 
Guerci B, Roussel R, Levrat-Guillen F, Detournay B, Vicaut E, de Pouvourville G, Emery C, Riveline JP. Important decrease in hospitalizations for acute diabetes events following FreeStyle Libre® system initiation in people with type 2 diabetes on basal insulin therapy in France. Diabetes Technol Ther. 2022 Sep 12. doi: 10.1089/dia.2022.0271. Epub ahead of print. PMID: 36094418
 
Mallone R, Halliez C, Rui J, Herold KC. The β-Cell in Type 1 Diabetes Pathogenesis: A Victim of Circumstances or an Instigator of Tragic Events? Diabetes. 2022 Aug 1;71(8):1603-1610. doi: 10.2337/dbi21-0036. PMID: 35881836
 
Monnier L, Colette C, Owens D. Three key indices in clinical practice to better comprehend the postprandial and basal glucose contributions in type 2 diabetes. Diabetes Technol Ther. 2022 Sep 12. doi: 10.1089/dia.2022.0286. Epub ahead of print. PMID: 36094415
 
Vergès B. Intestinal lipid absorption and transport in type 2 diabetes. Diabetologia. 2022 Oct;65(10):1587-1600. doi: 10.1007/s00125-022-05765-8. Epub 2022 Jul 30. PMID: 35908083
 
Wu Z, Yardley JE, Messier V, Legault L, Grou C, Rabasa-Lhoret R. Comparison of Nocturnal Glucose After Exercise Among Dual-Hormone, Single-Hormone Algorithm-Assisted Insulin Delivery System and Usual Care in Adults and Adolescents Living with Type 1 Diabetes: A Pooled Analysis. Diabetes Technol Ther. 2022 Oct;24(10):754-762. doi: 10.1089/dia.2022.0149. Epub 2022 Jun 24. PMID: 35653732

 

Août 2022

Denimal D, Monier S, Simoneau I, Duvillard L, Vergès B, Bouillet B. HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control. Cardiovasc Diabetol. 2022 Aug 12;21(1):154. doi: 10.1186/s12933-022-01591-9. PMID: 35962339 ; PMCID: PMC9375300
 
Guerci B, Giorgino F, Sapin H, Boye K, Lebrec J, Orsini Federici M, Heitmann E, Dib A, Füchtenbusch M, García-Pérez LE. The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Patient Disposition, Clinical Characteristics, and Treatment Persistence at 12 Months. Diabetes Obes Metab. 2022 Jul 25. doi: 10.1111/dom.14823. Epub ahead of print. PMID: 35876235
 
Hadjadj S, Saulnier PJ, Ruan Y, Zhu X, Pekmezaris R, Marre M, Halimi JM, Wargny M, Rea R, Gourdy P, Cariou B, Myers A, Khunti K and al (2022). Associations of microvascular complications with all-cause death in patients with diabetes and COVID-19: the CORONADO, ABCD Covid-19 audit and AMERICADO study groups. Diabetes Obes Metab. Accepted Author Manuscript. https://doi.org/10.1111/dom.14845
 
Marilly E, Cottin J, Cabrera N, Cornu C, Boussageon R, Moulin P, Lega JC, Gueyffier F, Cucherat M, Grenet G. SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits. Diabetologia. 2022 Aug 4. doi: 10.1007/s00125-022-05773-8. Epub ahead of print. PMID: 35925319
 
Wargny M, Croyal M, Ragot S, Gand E, Jacobi D, Trochu JN, Prieur X, Le May C, Goronflot T, Cariou B, Saulnier PJ, Hadjadj S; SURDIAGENE study group. Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort. Cardiovasc Diabetol. 2022 Jun 9;21(1):101. doi: 10.1186/s12933-022-01505-9. PMID: 35681209 ; PMCID: PMC9185908

 

Juin 2022

Bergman M, Buysschaert M, Medina JL, Tuomilehto J. Remission of T2DM requires early diagnosis and substantial weight reduction. Nat Rev Endocrinol. 2022 Jun;18(6):329-330. doi: 10.1038/s41574-022-00670-x. PMID: 35393576
 
Cariou B, Wargny M, Boureau AS, Smati S, Tramunt B, Desailloud R, Lebeault M, Amadou C, Ancelle D, Balkau B, Bordier L, Borot S, Bourgeon M, Bourron O, Cosson E, Eisinger M, Gonfroy-Leymarie C, Julla JB, Marchand L, Meyer L, Seret-Bégué D, Simon D, Sultan A, Thivolet C, Vambergue A, Vatier C, Winiszewski P, Saulnier PJ, Bauduceau B, Gourdy P, Hadjadj S; CORONADO investigators. Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative. Diabetologia. 2022 Jun 15:1–14. doi: 10.1007/s00125-022-05734-1. Epub ahead of print. PMID: 35701673 ; PMCID: PMC9197674
 
Riveline JP, Wojtusciszyn A, Guerci B, Alves C, Kao K, Xu Y, Dunn TC. Real world hypoglycemia related to glucose variability and flash glucose scan frequency assessed from global FreeStyle Libre data. Diabetes Obes Metab. 2022 Jun 13. doi: 10.1111/dom.14795. Epub ahead of print. PMID: 35695037
 
Wu Z, Yardley JE, Messier V, Legault L, Grou C, Rabasa-Lhoret R. Comparison of Nocturnal Glucose After Exercise Among Dual-Hormone, Single-Hormone Algorithm-Assisted Insulin Delivery System and Usual Care in Adults and Adolescents Living with Type 1 Diabetes: A Pooled Analysis. Diabetes Technol Ther. 2022 Jun 24. doi: 10.1089/dia.2022.0149. Epub ahead of print. PMID: 35653732

 

Mai 2022

Bonnefond A, Semple RK. Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes. Diabetologia. 2022 May 27. doi: 10.1007/s00125-022-05720-7. Epub ahead of print. PMID: 35618782
 
Potier L, Mohammedi K, Saulnier PJ, Fumeron F, Halimi JM, Venteclef N, Marre M, Hadjadj S, Roussel R, Velho G. Plasma Adrenomedullin, Allelic Variations in the ADM Gene, and Risk for Lower-Limb Amputation in People With Type 2 Diabetes. Diabetes Care. 2022 May 18:dc212638. doi: 10.2337/dc21-2638. Epub ahead of print. PMID: 35583678
 
Reach G, Benarbia L, Benhamou PY, Delemer B, Dubois S, Gouet D, Guerci B, Jeandidier N, Lachgar K, Le Pape G, Leroy R, Masgnaux JH, Raclet P, Reznik Y, Riveline JP, Schaepelynck P, Vambergue A, Vergès B. An Unsafe/Safe Typology in People with Type 2 Diabetes: Bridging Patients’ Expectations, Personality Traits, Medication Adherence, and Clinical Outcomes. Patient Prefer Adherence. 2022;16:1333-1350 https://doi.org/10.2147/PPA.S365398.
 
Riveline JP, Roussel R, Vicaut E, de Pouvourville G, Detournay B, Emery C, Levrat-Guillen F, Guerci B. Reduced rate of acute diabetes events with flash glucose monitoring is sustained for two-years after initiation: extended outcomes from the RELIEF study. Diabetes Technol Ther. 2022 May 23. doi: 10.1089/dia.2022.0085. Epub ahead of print. PMID: 35604792
 
Sola-Gazagnes A, Pecquet C, Berré S, Achenbach P, Pierson LA, Virmoux-Buisson I, M'Bemba J, Elgrably F, Moguelet P, Boitard C, Caillat-Zucman S, Laanani M, Coste J, Larger E, Mallone R. Insulin allergy: a diagnostic and therapeutic strategy based on a retrospective cohort and a case-control study. Diabetologia. 2022 May 4. doi: 10.1007/s00125-022-05710-9. Epub ahead of print. PMID: 35505238
 
Vambergue A, Madleen L, Desir C, Le Roux-Mallouf T, Tourki Y, Franc S, Lablanche S, Subtil D, Charpentier G, Benhamou PY. Management of pregnancy in a patient with highly unstable type 1 diabetes with DBL-hu closed-loop system. Diabetes Technol Ther. 2022 May 23. doi: 10.1089/dia.2022.0043. Epub ahead of print. PMID: 35604800

 

Avril 2022

Fève B, Scheen AJ. When therapeutic drugs lead to diabetes. Diabetologia. 2022 May;65(5):751-762. doi: 10.1007/s00125-022-05666-w. Epub 2022 Mar 4. PMID: 35244742
 
Monnier L, Colette C, Owens D. Below which threshold of glycemic variability is there a minimal risk of hypoglycemia in people with type 2 diabetes ? Diabetes Technol Ther. 2022 Mar 1. doi: 10.1089/dia.2022.0006. Epub ahead of print. PMID: 35230157
 
Mosbah H, Vantyghem MC, Nobécourt E, Andreelli F, Archambeaud F, Bismuth E, Briet C, Cartigny M, Chevalier B, Donadille B, Daguenel A, Fichet M, Gautier JF, Janmaat S, Jéru I, Legagneur C, Leguier L, Maitre J, Mongeois E, Poitou C, Renard E, Reznik Y, Spiteri A, Travert F, Vergès B, Zammouri J, Vigouroux C, Vatier C. Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real-life experience from a national reference network. Diabetes Obes Metab. 2022 Apr 20. doi: 10.1111/dom.14726. Epub ahead of print. PMID: 35445532

 

Mars 2022

Delsart P, Lemaitre M, Vambergue A, Ninni S, Bauters C, Ledieu G, Eymard DF, Baudoux F, Le Chevalier De Preville A, Sobocinski J, Montaigne D, Mounier-Vehier C. Prognostic significance of reverse dipping status on lower limb event in type 2 diabetic patients without peripheral arterial disease. Acta Diabetol. 2022 Mar 25. doi: 10.1007/s00592-022-01879-y. Epub ahead of print. PMID: 35333978
 
Gautheron J, Lima L, Akinci B, Zammouri J, Auclair M, Ucar SK, Ozen S, Altay C, Bax BE, Nemazanyy I, Lenoir V, Prip-Buus C, Acquaviva-Bourdain C, Lascols O, Fève B, Vigouroux C, Noel E, Jéru I. Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes. BMC Med. 2022 Mar 28;20(1):95. doi: 10.1186/s12916-022-02296-2. PMID: 35341481 ; PMCID: PMC8958798
 
Gerbaud E, Bouchard de La Poterie A, Baudinet T, Montaudon M, Beauvieux MC, Lemaître AI, Cetran L, Seguy B, Picard F, Vélayoudom FL, Ouattara A, Kabore R, Coste P, Domingues-Dos-Santos P, Catargi B. Glycaemic Variability and Hyperglycaemia as Prognostic Markers of Major Cardiovascular Events in Diabetic Patients Hospitalised in Cardiology Intensive Care Unit for Acute Heart Failure. J Clin Med. 2022 Mar 11;11(6):1549. doi: 10.3390/jcm11061549. PMID: 35329874 ; PMCID: PMC8951492
 
Rigalleau V, Larroumet A, Mohammedi K, Baillet-Blanco L, Monlun M, Delyfer MN, Korobelnik JF, Foussard N. Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care. 2021;44:2518-2526. Diabetes Care. 2022 Mar 1;45(3):e60. doi: 10.2337/dc21-2254. PMID: 35245355

 

Février 2022

Bonnet JB, Nicolet G, Papinaud L, Avignon A, Duflos C, Sultan A. Effects of social deprivation and healthcare access on major amputation following a diabetic foot ulcer in a French administrative area: Analysis using the French claim data. Diabet Med. 2022 Feb 24:e14820. doi: 10.1111/dme.14820. Epub ahead of print. PMID: 35213066
 
Croyal M, Wargny M, Chemello K, Chevalier C, Blanchard V, Bigot-Corbel E, Lambert G, Le May C, Hadjadj S, Cariou B. Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes. Cardiovasc Diabetol. 2022 Feb 7;21(1):21. doi: 10.1186/s12933-022-01452-5. PMID: 35130909 ; PMCID: PMC8822824
 
Kariyawasam D, Morin C, Casteels K, Le Tallec C, Sfez A, Godot C, Huneker E, Garrec N, Benhamou PY, Polak M, Charpentier G, Franc S, Beltrand J. Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial. Lancet Digit Health. 2022 Mar;4(3):e158-e168. doi: 10.1016/S2589-7500(21)00271-5. PMID: 35216750
 
Raverdy V, Cohen RV, Caiazzo R, Verkindt H, Petry TBZ, Marciniak C, Legendre B, Bauvin P, Chatelain E, Duhamel A, Drumez E, Oukhouya-Daoud N, Chetboun M, Baud G, Ahlqvist E, Wierup N, Asplund O, Laferrère B, Groop L, Pattou F. Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study. Lancet Diabetes Endocrinol. 2022 Mar;10(3):167-176. doi: 10.1016/S2213-8587(22)00005-5. Epub 2022 Feb 8. PMID: 35148818

 

Janvier 2022

Benhamou PY, Lablanche S, Vambergue A, Pou S, Madrolle S, Romero-Ugalde H, Franc S, Charpentier G. Beneficial effects of closed-loop insulin delivery in highly unstable type 1 diabetes eligible for islet transplantation are maintained over 6 months. An extension study of DBLHU-WP10 trial. Diabetes Obes Metab. 2022 Jan 31. doi: 10.1111/dom.14654. Epub ahead of print. PMID: 35099098
 
Cariou B. The metabolic triad of non-alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment. Diabetes Obes Metab. 2022 Feb;24 Suppl 2:15-27. doi: 10.1111/dom.14651. Epub 2022 Jan 24. PMID: 35014161
 
Diallo A, Pichelin M, Wargny M, Gourdy P, Bonnet JB, Hadjadj S, Cariou B, Sultan A, Galtier F; CORONADO investigators. Influenza vaccination and prognosis for COVID-19 in hospitalized patients with diabetes: Results from the CORONADO study. Diabetes Obes Metab. 2022 Feb;24(2):343-347. doi: 10.1111/dom.14577. Epub 2021 Oct 25. PMID: 34658131 ; PMCID: PMC8652659
 
Feldman-Billard S, Paques M. Comment on Lee et al. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study. Diabetes Care. 2021;44:2419-2426. Diabetes Care. 2022 Feb 1;45(2):e37. doi: 10.2337/dc21-1878. PMID: 35050371
 
Lohan L, Clément F, Duflos C, Villiet M, Castet-Nicolas A, Boegner C, Avignon A, Sultan A, Breuker C. Hypoglycemia While Driving in Insulin-Treated Patients: Incidence and Risk Factors. J Patient Saf. 2021 Dec 1;17(8):e1034-e1039. doi: 10.1097/PTS.0000000000000764. PMID: 32773647
 
Lohan L, Galtier F, Manson T, Mura T, Castet-Nicolas A, Faure D, Chapet N, Leclercq F, Pasquié JL, Roubille F, Roubille C, Blain H, Guilpain P, Villiet M, Avignon A, Sultan A, Breuker C. Compliance with Prescription Guidelines for Glucose-Lowering Therapies According to Renal Function: Real-Life Study in Inpatients of Internal Medicine, Endocrinology and Cardiology Units. Medicina (Kaunas). 2021 Dec 17;57(12):1376. doi: 10.3390/medicina57121376. PMID: 34946320 ; PMCID: PMC8704212
 
Renard E, Riveline JP, Hanaire H, Guerci B; investigators of France Adoption Clinical Trial. Reduction of clinically important low glucose excursions with a long-term implantable continuous glucose monitoring (CGM) system in adults with type 1 diabetes prone to hypoglycemia. France Adoption randomized clinical trial. Diabetes Obes Metab. 2022 Jan 4. doi: 10.1111/dom.14644. Epub ahead of print. PMID: 34984786
 
Rigalleau V, Larroumet A, Mohammedi K, Baillet-Blanco L, Monlun M, Delyfer MN, Korobelnik JF, Foussard N. Comment on Ipp and Kumar. A Clinical Conundrum: Intensifying Glucose Control in the Presence of Advanced Diabetic Retinopathy. Diabetes Care. 2021;44:2192-2193. Diabetes Care. 2022 Feb 1;45(2):e39. doi: 10.2337/dc21-2071. PMID: 35050369